Revenue
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | €7.2M | €6.4M | €7.9M | €10.3M | €10.0M | €3.0M |
| Research & development | €33.9M | €34.3M | €29.6M | €32.2M | €32.9M | €27.3M |
| Operating expenses | €42.3M | €42.0M | €37.9M | €40.2M | N/A | N/A |
| Operating income | −€35.1M | −€35.7M | −€30.0M | −€29.9M | −€23.5M | −€24.0M |
| Operating margin | −486.26% | −561.28% | −380.34% | −289.10% | −235.41% | −804.86% |
| EBITDA | −€33.7M | −€34.4M | −€28.5M | −€28.2M | −€21.0M | N/A |
| EBITDA margin | −467.86% | −541.11% | −360.44% | −272.80% | −210.19% | N/A |
| Net income | −€37.5M | −€34.0M | −€22.3M | −€32.8M | −€19.5M | −€17.2M |
| Net profit margin | −520.44% | −534.72% | −282.63% | −317.13% | −195.50% | −578.03% |
| Basic EPSper basic share | -€0.26 | -€0.29 | -€0.22 | -€0.33 | -€0.21 | -€0.21 |
| Diluted EPSper diluted share | -€0.26 | -€0.29 | -€0.22 | -€0.33 | -€0.21 | -€0.21 |
Reported shareholders and owner groups
| Holder | Ownership |
|---|---|
| 78.29%Sep 28, 2026 | |
| 3.55%Sep 28, 2026 |
These Euronext company-profile figures report shares in the company's capital. Named holders and owner groups are shown as published; free float, treasury shares, and unspecified holders are excluded from the colored segments.
Gray completes the 100% scale; it is not an estimate of other owners.
Transgene ($TNG) reported €92.8 million in cash, cash equivalents and other current financial assets at its half-year end, compared with €111.9 million at the start of the year. First-half cash burn increased to €20.3 million from €18.8 mil ...